Results 51 to 60 of about 15,173,912 (274)
Factor XI deficiency in women [PDF]
American Journal of Hematology, 1999 Factor XI (FXI) deficiency is an uncommon autosomally transmitted coagulopathy found predominantly in Jewish kindreds. It is associated with variable bleeding tendency that usually manifests after trauma, surgery, or other challenges to hemostasis. Therefore, women with FXI deficiency are at risk of excessive bleeding during their menstrual periods ...
R A, Kadir, D L, Economides, C A, Lee
openaire +2 more sources
JA Clinical Reports, 2016 Factor XI deficiency is rare but may cause life-threatening bleeding during the perioperative period. The clinical manifestation of factor XI deficiency is characterized by bleeding tendency.
Sachio Yoshikawa +3 more
doaj +1 more source
Anaesthesia management of caesarean section in a patient with severe factor XI deficiency
Journal of Obstetric Anaesthesia and Critical Care, 2013 Factor XI deficiency is a rare coagulation disorder associated with bleeding tendency and prolonged APTT. Parturients can have increased bleeding during vaginal delivery or cesarean section.
Debesh Bhoi +4 more
doaj +1 more source
Perioperative care of an adolescent with factor XI deficiency during posterior spinal fusion. [PDF]
Pediatric Anesthesia and Critical Care Journal (PACCJ)Factor XI (FXI) deficiency (Rosenthal disease or hemo- philia C) is a uncommon autosomal recessive bleeding disorder. Clinical signs and symptoms of factor XI de- ficiency are generally limited; however, significant bleeding may occur following trauma or
G. Parizek +3 more
doaj +1 more source
Protease: Serpin complexes to assess contact system and intrinsic pathway activation
Research and Practice in Thrombosis and Haemostasis, 2020 Mounting evidence suggests that a variety of disease states are pathophysiologically related to activation of the contact system in vivo. The plasma contact system is composed of a cascade of serine proteases initiated by surface activation of factor XII,
Michael W. Henderson +6 more
doaj +1 more source
Factor XI inhibitors - Rising stars in anti-thrombotic therapy?
Journal of Neurological SciencesThe "holy grail" of preventing and treating thrombosis and thromboembolism would be a drug that was highly effective (preventing clots) and at the same time had a low risk of bleeding.
C. Nolte
semanticscholar +1 more source
The evolution of factor XI and the kallikrein-kinin system.
Blood Advances, 2020 Factor XI (FXI) is the zymogen of a plasma protease (FXIa) that contributes to hemostasis by activating factor IX (FIX). In the original cascade model of coagulation, FXI is converted to FXIa by factor XIIa (FXIIa), a component, along with prekallikrein ...
M. Ponczek +9 more
semanticscholar +1 more source
Factor XI inhibition in cardiovascular medicine: current evidence and future clinical perspectives
Cardiologia HungaricaAnticoagulation plays a central role in the prevention and treatment of thromboembolic complications in cardiovascular disease. Although currently available anticoagulants targeting thrombin or factor Xa have substantially improved clinical outcomes ...
István Szegedi +2 more
doaj +1 more source
Coronary artery stenting in a patient with factor XI deficiency
Cardiology Plus, 2019 Factor XI deficiency is a rare coagulopathy which has a higher risk of bleeding following trauma or an operation. Stable coronary artery disease patients complicated by factor XI deficiency draw extraordinary caution when coronary artery stents are ...
Mingqiang Fu +4 more
doaj +1 more source
Misperception of Body Weight After Childhood Cancer
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Misperception of body weight can negatively impact the weight management efforts of childhood cancer survivors (CCSs). Both being overweight or underweight are associated with chronic health conditions commonly observed in CCS; therefore, accurate weight perception is critical for reducing long‐term health risks.
Fabiën N. Belle +8 more
wiley +1 more source